← Open Payments lookup

KATHRYN HEBERT: Open Payments

NPI 1124346218 · YOUNGSVILLE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,292 in 80 payments from 17 companies in 2025. Trend: 2023 $1,703 · 2024 $1,037 · 2025 $1,292

Food & beverage: $1,292
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.13$196
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$165
Alkermes, Inc.10$155
ABBVIE INC.14$143
Vanda Pharmaceuticals Inc.7$136
Teva Pharmaceuticals USA, Inc.6$124
Janssen Pharmaceuticals, Inc2$49
Supernus Pharmaceuticals, Inc.2$43
Axsome Therapeutics, Inc.2$42
Braeburn Inc.2$41

Products named: CAPLYTA, ARISTADA, VRAYLAR, FANAPT, ABILIFY ASIMTUFII, REXULTI, UZEDY, AUSTEDO XR.

Industry payments across LA — which companies pay providers there.